Arnautovic A, Dalyanoglu H, Vallejo Castano L J, Garabet W, Mulorz J, Knapsis A, Düsing S, Schellinger I N, Schelzig H, Raaz U, Duran M, Wagenhäuser M U
Department of Vascular and Endovascular Surgery, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany.
Department of Cardiac Surgery, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University, Duesseldorf, Germany.
Front Cardiovasc Med. 2025 Aug 19;12:1600775. doi: 10.3389/fcvm.2025.1600775. eCollection 2025.
Abdominal aortic aneurysm (AAA) is a dynamic disease characterized by a continuous diameter progression. AAA may therefore be categorized in early-stage disease (small diameter AAA) and late-stage disease (large diameter AAA). To date, there is no effective therapy for patients in early stages, resulting in disease-specific stressors. This study was designed to quantify these stressors using a specifically designed questionnaire.
A self-designed 17-item questionnaire with categorical response options was distributed to patients with small AAA. The aim of the approach was to gain a deeper understanding of patients' quality of life (QoL), psychological state and attitudes towards hypothetical future treatment options.
122 patients were contacted, 63 of whom consented to participate in the study. The study cohort was predominantly older than 65 years, 84% were male and 56% had been diagnosed with small-size AAA less than 1 year ago. In summary, the AAA diagnosis has a significant impact on all aspects of personal health perception, including physical, social and mental health. The overall QoL was found to be impaired compared to the situation before the AAA diagnosis for most of the respondents, and the current treatment options were considered unsatisfactory. The majority of small AAA patients surveyed would be open to new (invasive) therapies to stop disease progression.
The diagnosis of AAA leads to a reduction in QoL, which impairs the physical, social and mental health, particularly affecting mental health. Patients would welcome treatment options in early stages of their disease.
腹主动脉瘤(AAA)是一种动态疾病,其特征是直径持续增大。因此,AAA可分为早期疾病(小直径AAA)和晚期疾病(大直径AAA)。迄今为止,早期患者尚无有效治疗方法,这导致了特定疾病的应激源。本研究旨在使用专门设计的问卷对这些应激源进行量化。
向小AAA患者发放一份自行设计的包含分类回答选项的17项问卷。该方法的目的是更深入地了解患者的生活质量(QoL)、心理状态以及对假设的未来治疗方案的态度。
联系了122名患者,其中63名同意参与研究。研究队列主要为65岁以上人群,84%为男性,56%在不到1年前被诊断为小尺寸AAA。总之,AAA诊断对个人健康认知的各个方面都有重大影响,包括身体、社会和心理健康。与AAA诊断前的情况相比,大多数受访者的总体生活质量受损,且目前的治疗方案被认为不尽人意。大多数接受调查的小AAA患者愿意接受新的(侵入性)治疗以阻止疾病进展。
AAA诊断导致生活质量下降,损害身体、社会和心理健康,尤其影响心理健康。患者在疾病早期会欢迎治疗方案。